Phase I/II clinical trial - Pédiatrie Sarcomes

Pédiatrie Sarcomes
Ouvert depuis le: 12.10.2023
Site: Paris
Public cible
A Phase 1/2 Dose Escalation and Dose Expansion Study of ZN-c3 in Combination With Gemcitabine in Adult and Pediatric Subjects With Relapsed or Refractory Osteosarcoma
Description de l'essai
This is a phase 1/2 study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma.